Detalles de la búsqueda
1.
Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Antibody Levels Following Second Dose of ChAdOx1 nCov-19 or BNT162b2 Vaccine in Residents of Long-term Care Facilities in England (VIVALDI).
J Infect Dis
; 226(11): 1877-1881, 2022 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35429382
2.
Strong peak immunogenicity but rapid antibody waning following third vaccine dose in older residents of care homes.
Nat Aging
; 3(1): 93-104, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37118525
3.
Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational cohort study.
Lancet Healthy Longev
; 3(7): e461-e469, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35813280
4.
Robust SARS-CoV-2-specific and heterologous immune responses in vaccine-naïve residents of long-term care facilities who survive natural infection.
Nat Aging
; 2(6): 536-547, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37118449
5.
Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study.
Lancet Healthy Longev
; 2(9): e544-e553, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34430954
6.
COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemia.
Cancer Cell
; 40(6): 584-586, 2022 06 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35588735
Resultados
1 -
6
de 6
1
Próxima >
>>